Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia
- PMID: 1263839
- DOI: 10.1016/0026-0495(76)90078-0
Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia
Abstract
To evaluate the role of protein intake in the altered growth hormone (GH) secretion of chronic renal failure, GH responses to mild exercise and to an oral glucose tolerance test were measured in ten uremic patients ingesting both low and normal protein diets. To delineate the effect of uremia on any interaction between GH and protein intake, tests were performed before dialysis, after daily dialyses for 3-4 days and after withholding dialysis for 3-4 days. Results were as follows: (1) exercise-stimulated GH release was increased compared to controls; (2) protein intake did not alter GH secretion, (3) basal GH concentrations were significantly correlated with creatinine levels and were significantly lower after dialysis, (4) dialysis did not improve the oral glucose tolerance test, (5) there was no correlation between glucose tolerance and exercise-stimulated GH levels, basal GH concentrations, or the sum of GH values after glucose, and (6) dialysis significantly increased the insulin response to glucose.
Conclusions: In chronic renal failure enhanced GH secretion is not affected by protein intake, does not cause glucose intolerance, and may be related to the degree of uremia. Dialysis does not improve glucose tolerance, but does increase glucose-stimulated insulin release suggesting that insulin antagonism is not ameliorated.
Similar articles
-
Pattern of growth hormone response to insulin, arginine and haemodialysis in uraemic children.Eur J Pediatr. 1979 Jun 28;131(3):185-98. doi: 10.1007/BF00538942. Eur J Pediatr. 1979. PMID: 477677
-
Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats.Diabetes Res Clin Pract. 1998 Aug;41(2):85-94. doi: 10.1016/s0168-8227(98)00067-9. Diabetes Res Clin Pract. 1998. PMID: 9789714
-
The role of growth hormone in the glucose intolerance of uremia.Acta Diabetol Lat. 1979 Oct-Dec;16(4):279-86. doi: 10.1007/BF02587648. Acta Diabetol Lat. 1979. PMID: 399149
-
Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.J Pediatr Endocrinol. 1993 Jan-Mar;6(1):53-9. doi: 10.1515/jpem.1993.6.1.53. J Pediatr Endocrinol. 1993. PMID: 8374690 Review.
-
Carbohydrate metabolism in uremia.Pediatr Nephrol. 1989 Apr;3(2):201-8. doi: 10.1007/BF00852911. Pediatr Nephrol. 1989. PMID: 2701869 Review.
Cited by
-
Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.Pediatr Nephrol. 1990 Nov;4(6):654-62. doi: 10.1007/BF00858645. Pediatr Nephrol. 1990. PMID: 2088470 Review.
-
Growth hormone/insulin-like growth factor system in children with chronic renal failure.Pediatr Nephrol. 2005 Mar;20(3):279-89. doi: 10.1007/s00467-005-1821-0. Epub 2005 Feb 4. Pediatr Nephrol. 2005. PMID: 15692833 Review.
-
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products.Pharmaceutics. 2021 Apr 7;13(4):507. doi: 10.3390/pharmaceutics13040507. Pharmaceutics. 2021. PMID: 33917118 Free PMC article.
-
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.Drugs. 1995 Nov;50(5):805-37. doi: 10.2165/00003495-199550050-00004. Drugs. 1995. PMID: 8586028 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources